Table 3 Contains all clinically meaningful differences in scale values between participants in different age groups
From: Quality of life after cancer—How the extent of impairment is influenced by patient characteristics
Score | Age a | N | M ± SD | p-value | Difference |
|---|---|---|---|---|---|
PF | ≤39 | 129 | 71.7 ± 20.8 | .000 | 7.3 |
≥60 | 671 | 64.5 ± 20.5 | |||
EF | ≤39 | 126 | 54.47 ± 25.7 | .007 | 7.5 |
40–59 | 1014 | 46.9 ± 28.9 | |||
40–59 | 1014 | 46.9 ± 28.9 | .000 | 8.2 | |
≥60 | 652 | 55.0 ± 28.0 | |||
SF | ≤39 | 129 | 52.8 ± 30.1 | .001 | 9.9 |
≥60 | 677 | 62.8 ± 30.8 | |||
40–59 | 1029 | 56.2 ± 32.8 | .000 | 6.6 | |
≥60 | 677 | 62.8 ± 30.8 | |||
F | ≤39 | 128 | 51.1 ± 66.7 | .047 | 6.0 |
40–59 | 1039 | 57.1 ± 77.8 |